Leerink Lowers Biohaven (BHVN) PT to $50 Following Q2 Report, Acknowledging Positive Pipeline Progress
Biohaven Ltd. (NYSE:BHVN) is one of the best small cap stocks with biggest upside potential.
Biohaven Ltd. (BHVN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 5,620,271 | $79,302,024 | 2.39% | |
| 2. | Armistice Capital Steven Boyd | 2,136,000 | $30,138,960 | +28% | 0.52% |
| 3. | Millennium Management Israel Englander | 1,627,539 | $22,964,575 | +81% | 0.01% |
| 4. | Holocene Advisors Brandon Haley | 1,495,641 | $21,103,495 | +20% | 0.05% |
| 5. | 780,000 | $11,005,800 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.73 | 900 | $27,653.49 | 25,291 | 2025-03-04 | Filing | |
| $30.73 | 3,400 | $104,468.74 | 76,570 | 2025-03-04 | Filing | |
| $30.73 | 3,400 | $104,468.74 | 24,452 | 2025-03-04 | Filing | |
| $30.39 | 25,000 | $759,647.50 | 2,320,571 | 2025-03-04 | Filing | |
| $41.00 | 73,170 | $2,999,970.00 | 73,170 | 2024-04-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.79 | 11,000 | $459,662.50 | 2,535 | 2023-12-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,102,549 | $16,549,260 | 1.09% | |
| 2. | 332,288 | $4,987,643 | 2.37% | |
| 3. | 311,881 | $4,681,334 | 0.15% | |
| 4. | 284,439 | $4,269,423 | 0% | |
| 5. | 287,860 | $4,220,028 | 0.01% |
News See All
9 Best Small Cap Stocks with Biggest Upside Potential
On August 14, Jonathan Krinsky of BTIG, joined 'Closing Bell' on CNBC to discuss whether the recent rally in small cap stocks is sustainable.
Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders
Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd.
12 Best 52-Week Low Stocks to Buy According to Analysts
On July 15, the Consumer Price Index data revealed that core inflation increased by 0.2% on the month; however, the annual rate of 2.9% remains within the estimated range.
Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform
Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now.
13 Best Low Priced Pharma Stocks to Buy Now
On July 9, Afsaneh Beschloss, RockCreek Group founder & CEO, joined 'Closing Bell Overtime' on CNBC to talk about the latest round of tariff threats.
Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy”
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at where Biohaven Ltd.
Jim Cramer’s Thoughts on These 10 Stocks
Discussing how the market initially reacted, Cramer explained that when the panel of federal judges declared the majority of this year’s tariffs to be unlawful, S&P futures surged overnight.
Biohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy
Biohaven Ltd. (NYSE:BHVN) has announced major breakthroughs with its novel precision immunology therapies, BHV-1400 and BHV-1300, at its 2025 R&D Day in New Haven.
11 Stocks That Will Bounce Back According to Analysts
Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.